CIK 0001720580
- Non-accelerated filer
- Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813305277
- Phone
- +1 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-07 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-01-07 | Galimi Francesco SVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-01-07 | Healey Don Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-01-07 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +295,000 | 295,000 | ||
| 2022-01-05 | Jakobovits Aya Director | Sale | −2,000 | $16.93 | $34K | 364,343 |
| 2022-01-05 | Jakobovits Aya Director | Sale | −2,000 | $16.90 | $34K | 364,345 |
| 2022-01-03 | Jakobovits Aya Director | Sale | −6,000 | $18.02 | $108K | 366,343 |
| 2022-01-03 | Jakobovits Aya Director | Sale | −6,000 | $18.02 | $108K | 366,345 |
| 2021-12-10 | GORDON CARL L Director | Grant or award | +214,285 | $14.00 | $3.0M | 242,285 |
| 2021-12-10 | ORBIMED ADVISORS LLC Director | Grant or award | +214,285 | $14.00 | $3.0M | 242,285 |
| 2021-12-08 | Sinclair Andrew Director | Purchase | +500,000 | $14.00 | $7.0M | 2,115,385 |
| 2021-12-08 | Sinclair Andrew Director | Purchase | +500,000 | $14.00 | $7.0M | 2,140,721 |
| 2021-11-17 | Kauffman Michael Director | Grant or award · Stock Option (right to Buy) | +37,000 | 37,000 | ||
| 2021-10-12 | Aftab Blake Chief Scientific Officer | Grant or award | +80,000 | 80,000 | ||
| 2021-10-12 | Aftab Blake Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +60,000 | 60,000 | ||
| 2021-10-01 | Schor Chen President & CEO | Grant or award | +240,000 | 240,000 | ||
| 2021-10-01 | Healey Don Chief Technology Officer | Grant or award | +80,000 | 80,000 | ||
| 2021-10-01 | Galimi Francesco SVP & Chief Medical Officer | Grant or award | +80,000 | 86,983 | ||
| 2021-10-01 | Harvey Brian Nicholas Chief Financial Officer | Grant or award | +80,000 | 80,000 | ||
| 2021-06-16 | Schor Chen President & CEO | Sale | −7,484 | $10.53 | $79K | 74,841 |
Page 20 of 24 · 478 trades